The Beatrice Hunter Cancer Research Institute logo
  • Dr. Mark D. Berry, PhD

Appointments:

Professor and Head, Department of Biochemistry

Affiliations:

Memorial University of Newfoundland
Adjunct Professor, College of Pharmacy & Nutrition, University of Saskatchewan

Research Interests:

Chemotherapy, toxicity, alopecia, anxiety, depression, cognitive decline, programmed cell death, anti-apoptotics

Prevention of cancer chemotherapy-induced toxicity

We study the ability of small molecules to prevent chemotherapy-induced alopecia. Hair loss is regarded as one of the most traumatic aspects of chemotherapy, particularly for female and paediatric patients. We also examine the brain changes that occur during chemotherapy. There is growing evidence that the increased prevalence of anxiety and depression in cancer patients is not simply reactive to cancer diagnosis and/or chemotherapy side effects. We have recently identified a "chemobrain" and anorectic phenotype in our model system of chemotherapy-induced alopecia. By better understanding the basis of such effects, we hope to contribute to the development of therapies to decrease side effects and improve patient prognosis and quality of life.

Involvement with BHCRI to date:

Dr. Berry is a BHCRI Associate Member.

Phone:

709-864-8529

Contact:

SN 4006, Memorial University of Newfoundland, 232 Elizabeth Avenue, St. John’s, NL, Canada, A1B 3X9
Site by: Spectacle Group